Abstract
The urge to publish more and its consequences.
Highlights
In the era of “big science”, all researchers, academics and students are under pressure to publish more and to report more research activities for successful grant applications, academic promotion, and course graduation
Large amount of funding for research, publishing and archiving activities comes from pharmaceutical agencies, supporting individuals and their research and academic institutions
Non-disclosure of relevant relationships with pharma is a misconduct with far-reaching healthcare consequences that cannot be avoided even after corrections or retractions of unethical publications
Summary
In the era of “big science”, all researchers, academics and students are under pressure to publish more and to report more research activities for successful grant applications, academic promotion, and course graduation. Large amount of funding for research, publishing and archiving activities comes from pharmaceutical agencies, supporting individuals and their research and academic institutions. * Correspondence: Mohammad.Abdollahi@UToronto.Ca 1Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran 1417614411, Iran Full list of author information is available at the end of the article
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
